CAS NO.: 1258984-36-9
Synonyms: Nusinersen USP/EP/BP
Molecular Formula: C234H340N61O128P17S17
Molecular Weight：7127.194237
Application: Nusinersen, marketed as Spinraza, is a medication used in treating spinal muscular atrophy (SMA), a rare neuromuscular disorder. In December 2016, it became the first approved drug used in treating this disorder.
Any product involved in patent will be used for research purposes only.